BAQSIMI
As listed in the register: BAQSIMI 3 mg, poudre nasale en récipient unidose
3 mg · poudre
- Prescription only
- Active substance
- Glucagon
- Made by
- AMPHASTAR FRANCE PHARMACEUTICALS
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
BulgariaNo exact match for this strength and form
European UnionNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | AMPHASTAR FRANCE PHARMACEUTICALS |
|---|---|
| Active substance | Glucagon |
| Strength | 3 mg |
| Form | poudre |
| Route | nasale |
| Dispensing (as stated by the register) | liste I |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/19/1406 |
| Name in the register | BAQSIMI 3 mg, poudre nasale en récipient unidose |
| Packs | 1 récipient(s) unidose(s) polyéthylène polypropylène |
| CIS | 67972497 |
| CIP13 | 3400930195291 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).